Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Resources for Providers

Providers who would like to refer a patient to be evaluated for our innovative hemimegalencephaly treatment can email us or contact the Neonatal Neurology and Neonatal Neurocritical Care Program at 202-476-2120.

Additional information about our treatment approach:

  • Endovascular embolic hemispherectomy: A strategy for the initial management of catastrophic holohemispheric epilepsy in the neonate
    • Read our published article explaining in detail Children’s National’s experience with two neonates with hemimegalencephaly and intractable seizures. You'll find detailed information about how we managed these patients using a strategy of initial minimally invasive embolization of the cerebral blood supply to the involved hemisphere.
  • Staged transarterial hemispheric embolization: An innovative and effective treatment option for intractable seizures in newborns with hemimegalencephaly (HME)
    • Review our research poster detailing our experience with five newborns with HME and intractable seizures who underwent staged targeted transarterial embolization (TAE).